TherOx (R) AO system: hyperoxemic perfusion for myocardial infarction
Parrella, A
Record ID 32006000642
English
Authors' recommendations:
The TherOx aqueous oxygen (AO) System aims at recovering/reversing myocardial damage from an acute myocardial infarction (AMI). Although it is not yet available for commercial use outside of Europe, there is potential for this therapy to benefit a significant proportion of the Australian population. A subgroup analysis of a high level trial (level II evidence) indicated that this therapy may be safe and effective for patients with certain indications. It is therefore recommended that a Horizon Scanning report be conducted.
Details
Project Status:
Completed
Year Published:
2005
URL for published report:
Not Available
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Australia
MeSH Terms
- Infusions, Intra-Arterial
- Myocardial Reperfusion
- Coronary Circulation
- Myocardial Infarction
- Oxygen
Contact
Organisation Name:
Adelaide Health Technology Assessment
Contact Address:
School of Public Health, Mail Drop 545, University of Adelaide, Adelaide SA 5005, AUSTRALIA, Tel: +61 8 8313 4617
Contact Name:
ahta@adelaide.edu.au
Contact Email:
ahta@adelaide.edu.au
Copyright:
Adelaide Health Technology Assessment (AHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.